Prof. Cappato at the 13th Annual European Cardiac Arrhythmia Society Congress
On April 2nd to 4th, the 13th annual European Cardiac Arrhythmia Society (ECAS) congress was held in Rome with ECAS president Professor Riccardo Cappato presiding. In addition to being the president of the ECAS, Prof. Cappato is a professor at Humanitas University, the Cardiology, Electrophysiology and Arrhythmology unit director at Humanitas Research Center, director of the Arrhythmia and Electrophysiology II Center at Humanitas Gavazzeni Clinics, Bergamo, Italy, and a fellow of the European Society of Cardiology and the Heart Rhythm Society.
The congress was held at the prestigious Hotel Westin Excelsior on via Veneto, celebrated in cinema and the Dolce Vita by Hollywood stars such as Paul Newman, Liza Minelli, Elizabeth Taylor and Richard Burton.
ECAS allows like-minded specialists to meet and share their knowledge in addition to providing a platform where the advancements in the fields of Cardiology, Electrophysiology and Arrhythmology and others can be showcased. The congress’s success was due in part to the exclusive face-to-face discussion between the world’s most authoritative faculty members as well as less experienced curious doctors. 
The main topics discussed in this year’s program were Atrial Fibrillation and Sudden Death.
Overall, 14 sessions were held on the most recent advances in electrophysiology, such as:
- Lead extraction management
- VT ablation
- CRT dysfunction
- ECG interpretation
These topics were presented in the 11 large, belle époque meeting rooms.
Prof. Cappato spoke in the first session on Sunday, April 2 titled, “Direct Aral Anticoagulation for Cardioversion of Persistent Atrial Fibrillation – presenting Using Continuous Rivaroxaban – (The X-Vert Trial).” During the Luncheon Panel later that day, Prof. Cappato was the chaired the presentation, “Managing Patients with AF – from risk stratification to interventions.” He was also the moderator of the anticoagulation trials and AF ablation session.
On Monday, April 3, Prof. Cappato participated in the Luncheon Panel titled, “Anticoagulation in the EP lab – what do we know so far?”
Prof. Cappato is also leading investigator of a patient-based worldwide atrial fibrillation ablation survey. He is a patent inventor of the Subcutaneous ICD developed by Cameron Health. He frequently serves as an invited speaker at major international meetings. He has published over 300 peer-reviewed journals and book chapters, and is on the editorial board of numerous cardiology journals.